The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles.

Aberrant c-myc expression patterns occur in human Burkitt's lymphoma cells, which consistently exhibit c-myc chromosomal translocations, mutations within and flanking the translocated allele, a loss of the block to transcription elongation in exon 1, and a promoter shift to use of the upstream P1 promoter. To define the mechanism responsible for the loss of transcription elongation blockage and resulting c-myc deregulation in Burkitt's lymphoma, we analyzed transcription patterns after transfer of normal and Burkitt's lymphoma c-myc alleles into murine cells and Xenopus oocyte germinal vesicles. We have determined that although the mutations within and surrounding several Burkitt's lymphoma c-myc alleles are not sufficient, in themselves, to abrogate the transcription elongation block, transcription initiation from the P2 promoter may be necessary to obtain the block to transcription elongation. To test directly the role of c-myc promoters in programming transcription elongation blockage, we analyzed transcription patterns from in vitro mutagenized c-myc genes containing deletions of either the P1 or P2 promoter. These data confirm that P1-initiated c-myc transcripts do not terminate at discrete sites near the 3' end of exon 1, whereas P2-initiated transcripts either terminate or read through the transcription block signals. Therefore, overexpression and/or constitutive expression from the c-myc P1 promoter may contribute to increased readthrough transcription in Burkitt's lymphoma cells and, hence, to aberrant expression patterns or levels of c-myc steady-state transcripts. In addition, the ability of normal cells to modulate c-myc P2-initiated transcription to either read through or to block elongation provides a fine control mechanism over c-myc steady-state RNA levels.

[1]  W. C. Forrester,et al.  High-level beta-globin expression after retroviral transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Eick,et al.  Expression of normal and translocated c‐myc alleles in Burkitt's lymphoma cells: evidence for different regulation. , 1989, The EMBO journal.

[3]  M. Groudine,et al.  Expression of replication-dependent histone genes in avian spermatids involves an alternate pathway of mRNA 3'-end formation , 1989, Molecular and cellular biology.

[4]  J. Vieira,et al.  11 – Production of Single-Stranded Plasmid DNA , 1989 .

[5]  J. Bishop,et al.  DNA sequences that mediate attenuation of transcription from the mouse protooncogene myc. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Polack,et al.  The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation. , 1988, Oncogene.

[7]  R. Lucito,et al.  Elements required for transcription initiation of the human U2 snRNA gene coincide with elements required for snRNA 3′ end formation. , 1988, The EMBO journal.

[8]  C. June,et al.  Multiple mechanisms regulate c‐myc gene expression during normal T cell activation. , 1988, The EMBO journal.

[9]  L. Lau,et al.  c-myc can induce expression of G0/G1 transition genes. , 1988, Molecular and cellular biology.

[10]  K. Nishikura,et al.  The mechanism of inactivation of the normal c-myc gene locus in human Burkitt lymphoma cells. , 1988, Oncogene.

[11]  M. Groudine,et al.  Sequence requirements for premature termination of transcription in the human c-myc gene , 1988, Cell.

[12]  S. Freytag.  Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1 , 1988, Molecular and cellular biology.

[13]  R. Eisenman,et al.  A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas , 1988, Cell.

[14]  M. Groudine,et al.  Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. , 1987, Science.

[15]  Joyce Li,et al.  An elongation control particle containing the N gene transcriptional antitermination protein of bacteriophage lambda , 1987, Cell.

[16]  K. Yokoyama,et al.  Transcriptional control of the endogenous MYC protooncogene by antisense RNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Lachman,et al.  Contributions of transcriptional and post-transcriptional mechanisms to the regulation of c-myc expression in mouse erythroleukemia cells. , 1987, Genes & development.

[18]  S. Barik,et al.  An antitermination protein engages the elongating transcription apparatus at a promoter-proximal recognition site , 1987, Cell.

[19]  J. Vieira,et al.  Production of single-stranded plasmid DNA. , 1987, Methods in enzymology.

[20]  A. Polack,et al.  Transcription of c-myc in human mononuclear cells is regulated by an elongation block. , 1987, Oncogene.

[21]  B. Lebleu,et al.  Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells. , 1986, Nucleic acids research.

[22]  D. Eick,et al.  Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression. , 1986, Nucleic acids research.

[23]  K. Marcu,et al.  Intragenic pausing and anti‐sense transcription within the murine c‐myc locus. , 1986, The EMBO journal.

[24]  H. E. N. D. Vegvar,et al.  3′ end formation of U1 snRNA precursors is coupled to transcription from snRNA promoters , 1986, Cell.

[25]  E. Dmitrovsky,et al.  Expression of a transfected human c-myconcogene inhibits differentiation of a mouse erythroleukaemia cell line , 1986, Nature.

[26]  Mark Groudine,et al.  A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells , 1986, Nature.

[27]  P. Pelicci,et al.  Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Lacy,et al.  Induction of c-myc expression in human B lymphocytes by B-cell growth factor and anti-immunoglobulin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Hayday,et al.  Electric field-mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells , 1986, Molecular and cellular biology.

[30]  M. Cole.  The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.

[31]  C. Denny,et al.  Burkitt lymphoma cell line carrying a variant translocation creates new DNA at the breakpoint and violates the hierarchy of immunoglobulin gene rearrangement , 1985, Molecular and cellular biology.

[32]  C. Dani,et al.  c-myc gene is transcribed at high rate in G0-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors , 1985, Nature.

[33]  J. Blanchard,et al.  Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumors , 1985, Cell.

[34]  Jeffrey W. Roberts,et al.  Phage lambda gene Q antiterminator recognizes RNA polymerase near the promoter and accelerates it through a pause site , 1985, Cell.

[35]  S. Bauer,et al.  Chromosome translocations clustered 5′ of the murine c‐myc gene qualitatively affect promoter usage: implications for the site of normal c‐myc regulation. , 1985, The EMBO journal.

[36]  K. Nishikura,et al.  Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes , 1985, Molecular and cellular biology.

[37]  W. S. Hayward,et al.  Activation of a translocated c-myc gene: role of structural alterations in the upstream region. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Leder,et al.  Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Rabbitts,et al.  Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma , 1984, Nature.

[40]  P. Leder,et al.  Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in burkitt lymphoma , 1984, Cell.

[41]  S. Latt,et al.  A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) burkitt lymphoma , 1984, Cell.

[42]  C. Croce,et al.  Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Croce,et al.  Repression of rearranged mu gene and translocated c-myc in mouse 3T3 cells X Burkitt lymphoma cell hybrids. , 1984, Science.

[44]  P. Leder,et al.  Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells , 1984, Cell.

[45]  F. Galibert,et al.  Nucleotide sequence of the human c‐myc locus: provocative open reading frame within the first exon. , 1984, The EMBO journal.

[46]  J Erikson,et al.  Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. , 1983, Science.

[47]  B. Howard,et al.  High efficiency DNA-mediated transformation of primate cells. , 1983, Science.